EarCentric EasyCharge vs Lexie B3

The EarCentric EasyCharge is a budget-priced prescription hearing aid available for $229, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear rechargeable device ranks #36 of 39 prescription hearing aids tested, placing it in the bottom tier of its category. In our standardized testing, the EasyCharge demonstrates a stark performance divide. Its standout strength is feedback handling, scoring an excellent 5.0/5—slightly above the category average of 4.72. This means users can expect stable performance without whistling during typical daily activities. However, speech clarity metrics tell a different story: speech in quiet scores just 1.0/5, which is 2.40 points below the category average, and speech in noise also scores 1.0/5, falling 1.11 points below average. Music streaming scored 0.0/5, indicating this device is not suitable for audio enjoyment. Own-voice comfort is also limited at 1.9/5, which is 0.80 points below the prescription hearing aid average of 2.70. The device showed no improvement between initial and tuned fitting conditions, with both scoring 2.7/5. At this price point, shoppers should note that alternatives exist with meaningfully better performance. The RxEars Rxi, available in the same price range, scores 4.07/5. The EasyCharge may appeal to those prioritizing feedback-free operation on a tight budget, but its low speech clarity scores suggest significant limitations for everyday conversation.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.